Windlas Biotech Q1 Results
- BSE: 543329
- NSE: WINDLAS
- ISIN: INE0H5O01029
- Sector: Biotechnology & Drugs
BSE
855.90
-20.40 (-2.33%)
-20.40 (-2.33%)Volume385.00
Updated: Tue 10 Feb, 2026 | 15:12:35
NSE
850.65-20.75 (-2.38%)
-20.75 (-2.38%)Volume24.35 K
Updated: Tue 10 Feb, 2026 | 14:59:01
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q1 Results Highlights
Quarter ended Jun 25
Note: Comparison is on QoQ basis
Quarterly - Windlas Biotech Q1 Results
*All figures in crores except per share values
| Fiscal Period | Jun 25 | Mar 25 | QoQ Comp | Jun 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 191.01 | 185.49 | 2.98% | 160.48 | 19.02% |
| Depreciation/ Amortization | 7.45 | 8.33 | -10.64% | 6.21 | 19.94% |
| Operating Income | 19.08 | 17.21 | 10.82% | 14.67 | 30.03% |
| Net Income | 17.66 | 16.28 | 8.49% | 13.48 | 31.05% |
| Other Operating Expenses Total | 21.61 | 20.04 | 7.81% | 17.02 | 26.95% |
| Net Income Before Taxes | 23.26 | 20.82 | 11.69% | 18.31 | 27.01% |
| Total Revenue | 210.09 | 202.70 | 3.64% | 175.15 | 19.95% |
| Selling/ General/ Admin Expenses Total | 32.23 | 31.93 | 0.95% | 27.85 | 15.73% |
| Diluted Normalized EPS | 8.34 | 7.67 | 8.78% | 6.44 | 29.50% |